Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 78701-78750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05697328
Barotrauma in Hyperbaric Oxygen Therapy
NARecruiting
90 participants
Started: Jan 31, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05673538
TT-00973-MS Tablets in Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
40 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05590572
A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
PHASE1/PHASE2Not yet recruiting
148 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2027
1 condition6 sponsors5 locations
NCT05692115
Ischemia and Inflammatory Markers Among Patients With Coronary Artery Ectasia
N/ANot yet recruiting
90 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor0 locations
NCT06642831
Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
N/ARecruiting
380 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05709769
Radiomics-based Malnutrition for Cervical Cancer.
N/ARecruiting
150 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05242640
Understanding Components of Mind-body Exercise for Physical Activity Engagement in Metabolic Syndrome
NARecruiting
40 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05677490
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3Recruiting
382 participants
Started: Jan 31, 2023 · Completed: Nov 8, 2028
15 conditions2 sponsors777 locations
NCT06580418
Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
N/ARecruiting
40 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT05708170
Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
PHASE4Not yet recruiting
100 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors0 locations
NCT05505461
Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma
PHASE2Not yet recruiting
26 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06032403
Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations
NAActive, not recruiting
200 participants
Started: Jan 31, 2023 · Completed: Aug 31, 2025
1 condition6 sponsors1 location
NCT05589454
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
PHASE4Not yet recruiting
344 participants
Started: Jan 31, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors5 locations
NCT05378412
Effect of the 3C Model in Students and Teachers From Vaupés, Boyacá and Amazonas
NANot yet recruiting
6,000 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors0 locations
NCT05644197
Multidisciplinary Care After Prostatectomy
NANot yet recruiting
100 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor0 locations
NCT05520567
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
70 participants
Started: Jan 31, 2023 · Completed: Jul 31, 2028
2 conditions1 sponsor20 locations
NCT05677919
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
72 participants
Started: Jan 31, 2023 · Completed: Sep 3, 2030
2 conditions1 sponsor1 location
NCT05831566
Expertise Asthma COPD Program with Digital Support
PHASE3Recruiting
138 participants
Started: Jan 31, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05678647
Sucrosomial Iron and Iron Sulphate to Blood Donors
NAActive, not recruiting
120 participants
Started: Jan 31, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05468944
Robotic Transanal Specimen Extraction Surgery Versus Robotic Transabdominal Incision Specimen Extraction Surgery for Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial
NANot yet recruiting
556 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor12 locations
NCT05678322
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy
PHASE3Active, not recruiting
26 participants
Started: Jan 31, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05937178
Real-world Study Optimizing Nucleotide-analogues
N/ARecruiting
20,000 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2029
1 condition45 sponsors44 locations
NCT05607940
Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery
PHASE2/PHASE3Not yet recruiting
260 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05602168
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
NANot yet recruiting
400 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2030
1 condition1 sponsor0 locations
NCT05611359
Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer
NANot yet recruiting
60 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05659485
Measuring Family Engagement in Care (The FAME Study)
N/ARecruiting
198 participants
Started: Jan 31, 2023 · Completed: Dec 30, 2025
3 conditions3 sponsors6 locations
NCT05522205
Regulated Cannabis Access in Basel
NAActive, not recruiting
374 participants
Started: Jan 31, 2023 · Completed: Jul 31, 2025
3 conditions4 sponsors1 location
NCT05478538
Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform
N/ARecruiting
200 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor7 locations
NCT04818645
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
NARecruiting
477 participants
Started: Jan 31, 2023 · Completed: Jul 1, 2028
2 conditions2 sponsors1 location
NCT05715840
Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
PHASE3Not yet recruiting
368 participants
Started: Jan 31, 2023 · Completed: May 31, 2026
1 condition1 sponsor0 locations
NCT05613478
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
PHASE3Recruiting
130 participants
Started: Jan 31, 2023 · Completed: Nov 1, 2027
3 conditions2 sponsors1 location
NCT05015062
Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, China
NANot yet recruiting
4,000 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05732077
Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting
NARecruiting
100 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor13 locations
NCT05369520
Noninvasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury
NANot yet recruiting
30 participants
Started: Jan 31, 2023 · Completed: Sep 30, 2027
2 conditions2 sponsors2 locations
NCT06259591
Pedometer Coaching to Promote Postoperative Ambulation
NARecruiting
120 participants
Started: Jan 31, 2023 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT06604897
Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension
N/AActive, not recruiting
1,405 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05563337
Women Hypertensive and Young-Renal Denervation
NARecruiting
80 participants
Started: Jan 31, 2023 · Completed: Nov 30, 2028
1 condition1 sponsor6 locations
NCT05219383
Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
N/ANot yet recruiting
36 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05351242
Thermotherapy Against Persistent Bacterial LUNG Infections
NARecruiting
150 participants
Started: Jan 31, 2023 · Completed: Sep 30, 2026
6 conditions1 sponsor1 location
NCT06883201
Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
N/ARecruiting
78 participants
Started: Jan 31, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05601323
A Study of Suizenji in Patients With Unresectable Pancreatic Cancer
NARecruiting
90 participants
Started: Jan 31, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor7 locations
NCT04534153
Excipient Effect on Drug Absorption in Humans
EARLY_PHASE1Active, not recruiting
12 participants
Started: Jan 31, 2023 · Completed: Aug 18, 2025
1 condition2 sponsors1 location
NCT05679895
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
PHASE1Recruiting
12 participants
Started: Jan 31, 2023 · Completed: Jun 30, 2027
2 conditions4 sponsors2 locations
NCT06778343
Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
N/ARecruiting
134 participants
Started: Jan 31, 2023 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05413252
Team-based Care to Improve Hypertension
NAActive, not recruiting
90 participants
Started: Jan 31, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors2 locations
NCT05653817
Advanced or Metastatic Cholangiocarcinoma
NANot yet recruiting
60 participants
Started: Jan 31, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor0 locations
NCT05564806
Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma
PHASE1Recruiting
38 participants
Started: Jan 31, 2023 · Completed: Feb 7, 2026
2 conditions1 sponsor2 locations
NCT04866680
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
NARecruiting
165 participants
Started: Jan 31, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor8 locations
NCT05414526
Integrating Hypertension and Cardiovascular Diseases Care Into Existing HIV Services Package in Botswana (InterCARE)
NAActive, not recruiting
4,655 participants
Started: Jan 31, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor3 locations
NCT05689281
Increasing PrEP With Trans Women in the Deep South
NARecruiting
200 participants
Started: Jan 31, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location